<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Immunome AI Biotechnologies LLC</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <style>
    body {
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      margin: 0;
      padding: 0;
      background: #050816;
      color: #f5f5f5;
      line-height: 1.6;
    }
    header {
      padding: 3rem 1.5rem 1rem;
      text-align: center;
    }
    h1 {
      margin: 0 0 0.5rem;
      font-size: 2rem;
    }
    h2 {
      font-size: 1.1rem;
      font-weight: 500;
      opacity: 0.9;
      margin-top: 0;
    }
    main {
      max-width: 800px;
      margin: 0 auto;
      padding: 1rem 1.5rem 3rem;
    }
    section {
      margin-bottom: 1.5rem;
      padding: 1.25rem 1rem;
      border-radius: 10px;
      background: rgba(255, 255, 255, 0.03);
      border: 1px solid rgba(255, 255, 255, 0.06);
    }
    h3 {
      margin-top: 0;
      font-size: 1.05rem;
    }
    a {
      color: #7dd3fc;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
    ul {
      padding-left: 1.25rem;
      margin: 0.25rem 0 0.5rem;
    }
    footer {
      text-align: center;
      padding: 1rem 1.5rem 2rem;
      font-size: 0.85rem;
      opacity: 0.7;
    }
    .tag {
      display: inline-block;
      font-size: 0.75rem;
      padding: 0.1rem 0.45rem;
      border-radius: 999px;
      border: 1px solid rgba(255,255,255,0.15);
      margin-right: 0.35rem;
      margin-top: 0.25rem;
      opacity: 0.9;
    }
  </style>
</head>
<body>
  <header>
    <h1>Immunome AI Biotechnologies LLC</h1>
    <h2>Founder & Principal Architect: Rafid Quadir</h2>
  </header>

  <main>
    <section>
      <h3>Company Overview</h3>
      <p>
        Immunome AI Biotechnologies LLC is an early-stage company focused on 
        <strong>multi-omics, cardiovascular immunology, and endotype discovery</strong>.
        We build Cytoseeker, a platform that integrates biobank-scale data with
        single-cell and proteomic measurements to identify disease endotypes,
        biomarkers, and therapeutic targets.
      </p>
    </section>

    <section>
      <h3>Current Focus Areas</h3>
      <ul>
        <li>Coronary artery disease and myocardial infarction risk stratification.</li>
        <li>Integration of clinical, genetic, proteomic, and single-cell datasets.</li>
        <li>Endotype discovery and minimal marker panels for translational PoC.</li>
      </ul>
      <div>
        <span class="tag">Multi-omics</span>
        <span class="tag">Cardiovascular</span>
        <span class="tag">Biobanks</span>
        <span class="tag">Endotypes</span>
        <span class="tag">AI / GNN / Transformers</span>
      </div>
    </section>

    <section>
      <h3>Use of UK Biobank Data</h3>
      <p>
        As part of our early research program, we plan to use UK Biobank data to:
      </p>
      <ul>
        <li>Construct UKBB-style cardiovascular cohorts with standard CVD outcomes.</li>
        <li>Develop and evaluate endotype-driven risk models and minimal marker panels.</li>
        <li>Benchmark Cytoseeker against established clinical baselines and polygenic risk scores.</li>
      </ul>
      <p>
        Analyses will be conducted strictly within UK Biobank’s governance framework and
        used for methodological research and prototyping, not for direct clinical decision-making.
      </p>
    </section>

    <section>
      <h3>Contact</h3>
      <p>
        For collaborations or data access enquiries, please contact:<br />
        <strong>Email:</strong> <a href="mailto:info@immuneome-ai.com">info@immuneome-ai.com</a>
      </p>
    </section>
  </main>

  <footer>
    © <span id="year"></span> Immunome AI Biotechnologies LLC. All rights reserved.
  </footer>

  <script>
    document.getElementById("year").textContent = new Date().getFullYear();
  </script>
</body>
</html>
